PMGC Holdings (ELAB) Research & Development (2022 - 2026)

PMGC Holdings (ELAB) posted Research & Development of $108341.0 for Q1 2026, up 229.28% sequentially from $32902.0 in Q4 2025.

PMGC Holdings (ELAB) Research & Development (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Research & Development for 5 years, with the latest figure at $108341.0 in Q1 2026.

Quarterly Research & Development changed N/A year-over-year to $108341.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83962.0 (changed N/A YoY) and the FY2025 annual result came in at $147010.0, up 414.36% from the prior year.
Research & Development improved to $108341.0 in Q1 2026 per ELAB's latest filing, from $32902.0 in the prior quarter.
Over five years, Research & Development peaked at $73.3 million in Q3 2022 and troughed at -$134.6 million in Q4 2022.
A 5-year average of -$4.6 million and a median of $65830.0 in 2023 frame the typical range for Research & Development.
The widest YoY moves for Research & Development: up 538.93% in 2024, down 778.97% in 2024.
Over 5 years, Research & Development stood at -$134.6 million in 2022, then jumped by 100.03% to $35378.0 in 2023, then plunged by 778.97% to -$240205.0 in 2024, then surged by 113.7% to $32902.0 in 2025, then soared by 229.28% to $108341.0 in 2026.
According to Business Quant data, Research & Development over the past three periods registered $108341.0, $32902.0, and $15000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	993.80 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	1.63 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	651.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	612.28 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	413.13 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	210.03 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	97.90 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-588.31 Mn
10	PMGC Holdings	3.01 Mn	-15.78 Mn	385,691.00	310,219.00

Download Data